GO
Loading...

Valeant Pharmaceuticals International Inc

More

  • April 24- Zimmer Holdings Inc said on Thursday it would buy rival orthopedic products maker Biomet Inc for more than $13 billion, the latest deal in a wave of consolidations in the healthcare industry. The deal is expected to take Zimmer from the fourth-largest seller of orthopedics products to No. 2, behind Johnson& Johnson.

  • Morning six-pack: What we're reading Wednesday Wednesday, 23 Apr 2014 | 10:13 AM ET

    Happy Wednesday and welcome to the Morning Six-Pack, where we're always trying to beat analyst estimates and surprise to the upside.

  • I did not front-run Allergan stock, Ackman says Wednesday, 23 Apr 2014 | 9:40 AM ET
    Bill Ackman

    Bill Ackman also tells CNBC that Allergan's poison-pill defense doesn't make his takeover bid more difficult.

  • What burst of M&A activity says about the market Wednesday, 23 Apr 2014 | 6:31 AM ET
    Traders work on the floor of the New York Stock Exchange, April 16, 2014.

    The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.

  • Investor pressure pushing drugmaker M&A deals Wednesday, 23 Apr 2014 | 6:11 AM ET
    Valeant Pharmaceuticals sign at the company's headquarters in Mississauga, Ontario.

    Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.

  • Asia shares mixed on lackluster China data Wednesday, 23 Apr 2014 | 12:06 AM ET

    TOKYO— Shares were mixed in Asia on Wednesday, as weak data from China sapped upward momentum from an overnight rally on a flurry of deals in the pharmaceutical sector. Overnight, U.S. financial data and corporate earnings helped spur gains from deals by Switzerland's Novartis with Britain's GlaxoSmithKline PLC and the Eli Lilly& Co. of the U.S.

  • Investor pressure pushing drugmaker M&A deals Tuesday, 22 Apr 2014 | 6:41 PM ET

    Swiss drugmaker Novartis AG on Tuesday said it's trading its vaccine business for GlaxoSmithKline Plc's cancer drug business and selling its veterinary drug business to Eli Lilly and Co. Meanwhile, Canadian drugmaker Valeant Pharmaceuticals International Inc. said it teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $45 billion.

  • Hostile Allergan bid: Cramer hopes Ackman whiffs Tuesday, 22 Apr 2014 | 6:16 PM ET

    Considering Cramer is a big fan of M&A, why is he so opposed to the Allergan takeover?

  • How the Dow Jones industrial average fared Tuesday Tuesday, 22 Apr 2014 | 5:13 PM ET

    The stock market logged its sixth straight day of gains on Tuesday. Netflix and Harley-Davidson both jumped after reporting earnings that beat analysts' expectations. Allergan, which makes Botox, jumped after Valeant Pharmaceuticals and activist investor Bill Ackman disclosed that they are trying to buy the company.

  • Netflix and Harley-Davidson are big market movers Tuesday, 22 Apr 2014 | 4:59 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. Harley-Davidson Inc., up $4.33 to $71.87. The Interpublic Group of Cos. Inc., up 49 cents to $17.36.

  • *Netflix up after results; Facebook gains on upgrade. Netflix Inc surged 7 percent to $372.90 a day after showing strong subscriber growth, a sign the trading favorite still had room to grow despite recent concerns over its valuation.

  • S&P 500 seals first six-day win streak since September Tuesday, 22 Apr 2014 | 4:16 PM ET

    U.S. stocks rose on Tuesday after earnings from McDonald's and Netflix.

  • After a rough year Bill Ackman is the comeback kid Tuesday, 22 Apr 2014 | 2:50 PM ET
    Bill Ackman

    Virtually every Pershing Square Capital investment appears to have made money this year.

  • Botox. It's more than just a wrinkle buster Tuesday, 22 Apr 2014 | 2:18 PM ET
    Botox by Allergan

    More than half the revenue from Botox comes from therapeutic, not cosmetic, use. And its potential is helping to make Allergan an attractive target.

  • US STOCKS-Earnings, healthcare help lift Wall Street Tuesday, 22 Apr 2014 | 2:03 PM ET

    *Netflix up after results, Facebook gains on upgrade. Healthcare, up 1.5 percent, was the best performing of the 10 major S&P sectors, as Allergan Inc jumped 15.8 percent to $164.48 a day after activist investor William Ackman teamed up with Canadian drugmaker Valeant Pharmaceuticals International Inc to bid for the company.

  • How one trader made $280,000 overnight on FURX Tuesday, 22 Apr 2014 | 1:15 PM ET
    Traders work the floor of the New York Stock Exchange.

    One astute trader picked up big money overnight by buying options in Furiex Pharmaceuticals.

  • Midday movers: Allergan, Comcast, Facebook & More Tuesday, 22 Apr 2014 | 12:43 PM ET
    A Comcast truck is seen parked at one of their centers on February 13, 2014 in Pompano Beach, Florida.

    Some of Tuesday's midday movers:

  • *Netflix up after results, Facebook gains on update. Dow components Travelers Cos Inc and United Technologies Corp both reported first-quarter earnings that beat expectations, and United Tech raised the low end of its full-year profit outlook. Shares of Travelers rose 0.2 percent to $86.58 while United Tech was up 1.2 percent at $119.69.

  • Europe shares close higher as pharma stocks surge Tuesday, 22 Apr 2014 | 11:57 AM ET

    European shares closed higher on Tuesday, starting a shortened trading week on a positive note.

  • Valeant and Allergan a 'perfect match': Shareholder Tuesday, 22 Apr 2014 | 11:32 AM ET
    Valeant Pharmaceuticals sign at the company's headquarters in Mississauga, Ontario.

    One of Valeant's top shareholders on Tuesday threw his support behind its proposed takeover bid for Botox-maker Allergan.

Most Popular Video

Thursday, 24 Apr 2014 | 10:02 AM ET

It's a very strong quarter for Apple, but the competition is doing well also, says Alex Gauna, JMP Securities senior research analyst, discussing the tech giant's strong quarterly earnings and 7-for-1 stock split.

Thursday, 24 Apr 2014 | 8:30 AM ET

CNBC's Jeff Cox discusses the future of Wall Street as well as whether or not New York will remain the financial capital of the world.

Thursday, 24 Apr 2014 | 9:39 AM ET

CNBC's Bob Pisani looks ahead at what's likely to move in early morning trading, as earnings come flooding in.